Mar 30 2009, 7:45 AM EST
News source: Business Wire
CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today announced the restructuring and expansion of its Medical Advisory Board (MAB). The Company added six new members and retained two original members, bringing the current size of the MAB to eight. CardioNet’s MAB is comprised of leading clinicians and researchers in the fields of cardiology, electrophysiology, thoracic surgery and neurology who advise the Company on its clinical programs and provide strategic guidance to support the commercial adoption of CardioNet’s Mobile Cardiac Outpatient Telemetry™ (MCOT™).
Peter R. Kowey, M.D., Medical Director and Chairman of CardioNet’s Medical Advisory Board, said, “The CardioNet Medical Advisory Board is a highly talented group of physicians. Their diverse expertise will help us to continue to advance the technology beyond what CardioNet is today, to benefit even more patients with cardiovascular disease. I am excited to chair this extraordinary group.”
Randy Thurman, Chairman, President and Chief Executive Officer of CardioNet, said, “We are very pleased to welcome the new members of our Medical Advisory Board. Our Medical Advisory Board will be instrumental in the achievement of CardioNet’s strategic imperatives as well as our mission to become the leader in wireless medicine. The MAB will not only enhance our strategies with respect to MCOT, but it will also contribute significantly as we explore adjacent markets to expand our current business and work with us to integrate new therapeutic and diagnostic modalities into our platform technology. The addition of these new members to our Medical Advisory Board is further reinforcement of CardioNet’s leadership position in mobile cardiac outpatient telemetry and a clear reflection of the company’s potential. CardioNet is honored to welcome this extraordinarily accomplished group of physicians and scientists to the company.”
CardioNet’s Medical Advisory Board is comprised of the following members:
Peter R. Kowey, M.D., FACC, FACP, FACCP, FCP – Medical Director and Chairman of the Medical Advisory Board
Dr. Kowey joined CardioNet as its Medical Director in 2002 and was named Chairman of the MAB in March, 2009. He is Chief of the Division of Cardiovascular Diseases for the Main Line Health System, including Lankenau Hospital. He is also Professor of Medicine and Clinical Pharmacology at Jefferson Medical College, and President of the Heart Center of the Main Line Health System. He has served as a member of the Cardiorenal Drug Advisory Committee and the Cardiovascular Devices Committee of the U.S. Food and Drug Administration and holds the William Wikoff Smith Chair in Cardiovascular Research. Dr. Kowey received his medical degree from the University of Pennsylvania School of Medicine.
David G. Benditt, M.D., FACC, FRCP(C), FHRS
Dr. Benditt is Professor of Medicine and Co-Director of the Cardiac Arrhythmia and Syncope Center at University of Minnesota Medical School. Dr. Benditt is a past president of the North American Society for Pacing and Electrophysiology (now known as the Heart Rhythm Society). He currently is an Associate editor with the Journal of Interventional Electrophysiology (JICE) and is an editorial board member of the Journal of the American College of Cardiology (JACC), Europace, and the American Journal of Cardiology (AJC). Dr. Benditt received his medical degree from the University of Manitoba.
Kenneth A. Ellenbogen, M.D., FACC
Dr. Ellenbogen is the Vice-Chairman of Cardiology at Virginia Commonwealth University (VCU) and was awarded the Kontos Endowed Professorship in 2000. He also serves as Director of Clinical Cardiac Electrophysiology and Pacing at both VCU’s MCV Campus and the McGuire Veterans Administration Medical Center. Dr. Ellenbogen serves on the editorial boards of the Journal of the American College of Cardiology, American Journal of Cardiology, American Heart Journal, Circulation, the Journal of Cardiovascular Electrophysiology, Heart Rhythm and is one of the Senior Editors of PACE. Dr. Ellenbogen received his medical degree from Johns Hopkins University.
Scott Eric Kasner, M.D., MSCE, FAHA
Dr. Kasner is Associate Professor of Neurology and Director of the Comprehensive Stroke Center at the Hospital of the University of Pennsylvania. He is a member of the leadership committee of the American Stroke Association and is on the editorial board of the Journal of Stroke and Cerebrovascular Disease, as well as the stroke section editor of UpToDate. Dr. Kasner received his medical degree from Yale Medical School.
Arthur J. Moss, M.D.
Dr. Moss is Professor of Medicine (Cardiology) and Professor of Community and Preventive Medicine at University of Rochester School of Medicine and Dentistry. He is also the Director of the Heart Research Follow-up Program at the University of Rochester Medical Center and Editor-in-Chief for the Annals of Noninvasive Electrocardiology. Dr. Moss received his medical degree from Harvard Medical School.
Evelio Rodriguez, M.D., FACS
Dr. Rodriguez is a practicing cardiothoracic surgeon at the Brody School of Medicine, East Carolina University, where he is Assistant Professor of Surgery and Pediatrics in the Department of Cardiovascular Sciences. Dr. Rodriguez received his medical degree from Albany Medical College.
Philip Sager, M.D., FACC, FAHA, FHRS
Dr. Sager is Chief Medical Officer of CardioDx, Inc., a privately-held cardiovascular genomic diagnostics company based in Palo Alto, CA. He is Co-Chair of the Scientific Oversight Committee and Executive Committee member of the FDA-sponsored Cardiac Safety Research Consortium. He is also a member of the International Committee on Harmonization (ICH E14 Implementation Group). Dr. Sager received his medical degree from Yale School of Medicine.
William S. Weintraub, M.D., FACC, FAHA
Dr. Weintraub is the John H. Ammon Chair of Cardiology at Christiana Care Health System, Professor of Medicine at Jefferson University and Professor of Health Sciences at the University of Delaware. He is also director of the Christiana Center for Outcomes Research, which focuses on identifying and supporting “best practices” in medicine and improving health care. He is Chairman of the CathPCI Steering Committee for the American College of Cardiology National Cardiovascular Data Registry. Dr. Weintraub received his medical degree from Johns Hopkins University.
About CardioNet, Inc.
CardioNet is the leading provider of ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health. CardioNet's initial efforts are focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders, with a solution that it markets as Mobile Cardiac Outpatient Telemetry™ (MCOT™). More information can be found at http://www.cardionet.com.
Forward Looking Statements
This press release includes certain forward-looking statements within the meaning of the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995 regarding, among other things, our growth prospects, the prospects for our products and our confidence in the Company's future. These statements may be identified by words such as "expect", "anticipate", "estimate", "project", "intend", "plan", "believe", and other words and terms of similar meaning. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including important factors that could delay, divert, or change any of them, and could cause actual outcomes and results to differ materially from current expectations. These factors include, among other things, the success of our sales and marketing initiatives, our ability to attract and retain talented sales personnel, the commercialization of new products, market factors, internal research and development initiatives, partnered research and development initiatives, competitive product development, changes in governmental regulations and legislation, changes to reimbursement levels for our products, the continued consolidation of payors, acceptance of our new products and services and patent protection and litigation. For further details and a discussion of these and other risks and uncertainties, please see our public filings with the Securities and Exchange Commission, including our latest periodic report on Form 10-K or 10-Q. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.
ADVERTISEMENT
INTERVIEW:
NEW PROGNOSTIC GENETIC TEST FOR ADOLESCENT SCOLIOSIS - Interview with Dr. Baron Lonner, director of Scoliosis and Spine Associates
...MORE
NewsArticles BlogsADVERTISEMENT
Subscribe to RSS
Email
Print
Share
More News
Listen
Save
Comment
View All